Can You Be on TRT in the Military? The 2026 Answer by Duty Status

By TRT Provider Guide · Last verified: October 2026 (sources checked October 30, 2026)

Last updated: October 30, 2026. Last verified: October 30, 2026.

Educational information, not medical advice and not a military clearance decision. Editorial research; not clinically reviewed.

Can you be on TRT in the military? Yes, prescribed treatment for confirmed testosterone deficiency can be compatible with service. Under the Defense Health Agency's September 17, 2026 guideline, stable treatment is not, by itself, a reason to limit your duty. Entry standards, special-duty qualification, and theater deployment rules still apply.

Sources: DHA guideline and military medical standards.

Best for: U.S. adults seeking care for male testosterone deficiency while serving, applying, or planning to leave the military. Not for: a personal diagnosis, military clearance, nonmedical performance enhancement, or care for adolescents, women, or gender affirmation.

That's the short answer. But there's a catch. Two official military documents use different waiver language for testosterone therapy. We put them side by side below, along with the question to ask about your orders.

Testosterone without a valid prescription is a different story. It's a Schedule III controlled substance. DEA scheduling

TRT Provider Guide is the independent decision resource for testosterone replacement therapy — helping U.S. adults understand how low testosterone is evaluated, compare online and local care models and providers, and choose the next step that fits their health needs, fertility plans, budget, state, and care preferences, with every material claim verified and dated.

On this page: The status matrix · Will TRT get you in trouble? · What changed in 2026 · How diagnosis works · Treatment formats · Deploying on TRT · Special duty · Civilian and online clinics · Fertility · Risks and monitoring · Cost · Guard and Reserve · Joining · Leaving the service · Policy debate · Appointment worksheet · Research method · FAQ

---

Can you be on TRT in the military? Find your exact situation

Yes, but your duty status changes what you need to do. Active-duty members get screened and treated through the military health system. Special-duty members face a separate qualification review.

Guard and Reserve members often use civilian care and must report it. Applicants are judged by separate entry standards. The matrix below puts the main situations in one place.

We built this matrix to bring the clinical, duty, deployment, pharmacy, and entry questions into one place. It pulls from the DHA clinical guideline and screening announcement, TRICARE pharmacy rules, federal controlled-substance law, a CENTCOM deployment standard, and the published entry standards.

Military TRT status matrix

Matrix sources, checked October 30, 2026: DHA guideline, pp. 4–15 and Appendix C; TRICARE pharmacy handbook, pp. 13 and 19; referral rules; OPSS testosterone guidance; Air National Guard reporting advisory, p. 8; entry standards; separation and retirement.

The line that calms most readers down: the DHA guideline states that "neither a diagnosis of testosterone deficiency nor stable maintenance therapy is, of itself, a basis for a duty limitation or a change in deployment status." Special-duty qualification and theater deployment rules still apply on top of that. DHA guideline, p. 15

The right TRT path is not the same for every person — it depends on whether low testosterone has been properly evaluated, your symptoms and health history, your fertility plans, your state, your insurance or cash-pay preference, your treatment-format preference, your budget, and whether military, online, or in-person care is the better starting point. Some situations belong with primary care, urology, endocrinology, reproductive urology, or urgent or emergency care when the symptoms warrant it. Because a general answer cannot resolve those for you, use the appointment worksheet below with your military medical team to map the right care route and the questions to ask before you pay.

One limit to know up front: TRT Provider Guide's Find My TRT Path tool offers general online-program information. It does not decide military entry, retention, special-duty qualification, deployment clearance, or TRICARE authorization. Your military medical team helps coordinate review by the responsible authorities.

→ Prepare the questions for your military medical team

---

Will TRT get you in trouble in the military?

A valid prescription matters, but it does not replace military reporting, duty, or deployment requirements. Testosterone is a Schedule III controlled substance. Wrongful use, possession, or distribution can be prosecuted under UCMJ Article 112a.

The 2026 DHA guideline also says a diagnosis or stable treatment is not, on its own, a reason for a duty limitation, and that declining evaluation or treatment carries no adverse personnel consequence. DHA guideline, pp. 15 and 19; UCMJ Article 112a; DEA scheduling

This is the fear that sends most service members to search, so let's take it head on.

Prescribed TRT vs. "testosterone on your own"

Here's the line that matters:

• Prescribed, documented, monitored testosterone for a confirmed deficiency is medical treatment.
• Using or possessing testosterone without lawful authorization can be a controlled substance offense. UCMJ Article 112a covers wrongful use, possession, and distribution of controlled substances, and testosterone sits in Schedule III. A prescription for you does not authorize sharing it with someone else. UCMJ Article 112a; DEA prescription requirements

"Valid prescription" is the key phrase. A civilian prescription must meet the same requirements for a legitimate medical purpose and lawful prescribing. DEA prescription requirements But if you're on active duty, it also has to be reported to your military medical team. That's where people get burned, and we cover it in the civilian-clinic section.

Will it go on your profile or hurt your career?

Not automatically. The September 2026 guideline says neither the diagnosis nor stable maintenance therapy is, by itself, a basis for a duty limitation or a change in deployment status. Its informed-consent checklist includes a recorded statement that declining evaluation or treatment carries no adverse personnel consequence. DHA guideline, Appendix B

Two caveats keep that honest:

1. Special duty is separate. Aviation, dive, submarine, and nuclear qualifications follow their own Service rules. More below.
2. Retention standards are case by case. Military medical standards for staying in service are applied individually. No article can predict a medical board outcome, and we won't pretend to. Health.mil medical standards

Can a lab test reveal testosterone you didn't disclose?

Yes, and this matters more now than it used to. The 2026 guideline tells military clinicians that a testosterone level above the normal range in a member who isn't prescribed testosterone "requires evaluation and is not to be recorded as an incidental finding." It adds that suppressed LH and FSH (pituitary hormones involved in testicular function) are "the expected pattern of exogenous androgen exposure." That pattern can raise concern about outside androgen exposure, but it requires medical evaluation; it is not proof by itself. DHA guideline, p. 7 and Table A-1

The DHA's patient guidance is simple: if you're taking testosterone or another hormone you got outside your military care, tell your provider. It helps your provider interpret the results safely and keeps your medical record complete. DHA Men's Hormone Health

Does the military drug test for testosterone?

The military can conduct steroid testing. The Army's Fort Hood drug-testing page describes steroid testing separately from its routine urine panel; that is also different from the DHA's clinical testosterone-screening pathway. Keep your prescription records current and accessible, and ask your Service's drug-testing program how prescription documentation is reviewed. A prescription is not a guarantee about a test result or a personnel decision. U.S. Army drug-testing program; DHA guideline

One more trap: "testosterone booster" supplements are not TRT. The DoD's Operation Supplement Safety program warns that supplements can contain unlisted ingredients that may affect drug testing. A real prescription is documented. A gas-station booster isn't. OPSS testosterone and drug-testing guidance

More on prescribed testosterone, steroid misuse, and drug-testing contexts: TRT vs. steroids

Want the exact questions to bring to your PCM? Our printable worksheet is below. No sign-up, nothing to submit.

→ Jump to the Military TRT Appointment Worksheet

---

What changed for TRT in the military in 2026?

In 2026, the military added testosterone screening to routine health assessments and published a formal treatment pathway. A July 15, 2026 Secretary of War memo ordered screening for Active Duty and Reserve Component members 30 and older. A September 17, 2026 DHA guideline then defined how men are screened, diagnosed, and treated.

Treatment is voluntary. DHA guideline; DHA screening announcement; official July 15 announcement record

Here's the timeline, because the order matters. Earlier coverage describes guidance that was withdrawn and replaced.

Screening is not a prescription

Men 30 and older get a structured symptom and risk-factor screen at the PHA. Men under 30 are screened if they ask, or if the provider sees warning signs. Under this screening pathway, blood tests follow a positive screen or a listed risk factor, subject to the guideline's valid-testing conditions. DHA guideline, pp. 4–5

The guideline is unusually blunt about what TRT can and can't do. It says testosterone therapy has shown benefits for sexual function, body composition, and bone density. It also says the evidence does not support using it to improve energy, vitality, physical function, or thinking. And it states that guidance premised on performance enhancement "is not supportable on the current evidence." The DHA's patient page describes TRT as treatment for a diagnosed deficiency, not a performance shortcut. DHA guideline, p. 3; DHA Men's Hormone Health

That's worth knowing before you walk in. If you go in asking for an edge, you're asking for something the military's own guideline says TRT doesn't deliver.

---

How does the military diagnose low testosterone?

The September 2026 DHA guideline uses two fasting morning blood tests on separate days showing total testosterone under 300 ng/dL, plus symptoms that fit, as one diagnostic pathway. A normal total level with low free testosterone and matching symptoms can also qualify. One low number is never enough under this pathway, and the guideline excludes diagnostic samples taken too close to qualifying extreme training or acute illness. DHA guideline, pp. 4–7

This is the section that can save you from a wrong diagnosis.

The two-test rule, in plain words

Under the DHA guideline:

• Timing: drawn between 0700 and 1000. For night or rotating shifts, within three hours of your normal wake time after a normal sleep period.
• Fasting: yes.
• Two tests on separate days. About 30% of men with one low result are normal on the repeat test.
• LH and FSH are checked once, with the second draw, to help find the cause.
• Free testosterone is checked when your total level looks normal but symptoms persist, or when a condition affecting SHBG makes total testosterone harder to interpret. Free testosterone is the small share not bound to proteins. It's calculated using SHBG (sex hormone-binding globulin, a protein that carries testosterone in the blood). The guideline uses 66 pg/mL as the lower reference limit. Your clinician must interpret free testosterone using the laboratory's method and reference range.

The diagnosis requires both consistently low levels and symptoms. Neither one is enough alone. That core principle matches the Endocrine Society's civilian guideline; the exact cutoffs and testing details are not identical. DHA guideline; Endocrine Society guideline If you want the civilian version, see why TRT requires two low testosterone tests.

Why field weeks, cuts, and sleep loss can fake low T

This is the most important detail in the guideline for anyone in uniform. Hard training, sleep restriction, not eating enough, heat, altitude, and stress all temporarily push testosterone down. The guideline calls this an adaptation to energy scarcity, not a disease. It usually resolves within days of real rest and food. DHA guideline, Background

So the rule is strict: no diagnostic testosterone testing within 30 days of training that involved extreme physical or mental stress or sleep deprivation, and none during an acute illness or within 30 days of recovering from one. If you were diagnosed using blood drawn inside that window, the guideline says the diagnosis must be re-confirmed after recovery before treatment starts.

A detail we caught: the posted guideline's clinical section says 30 days, but its embedded Appendix F patient sheet says "at least two weeks." The separately linked DHA patient handout now also says 30 days after training involving extreme stress or sleep loss. The 30-day rule is the one clinicians are told to document. If you just came off a field problem, a selection course, or a weight cut, ask your provider to confirm the correct recovery interval before diagnostic testing. DHA guideline, pp. 5 and 24; separate DHA patient handout

Your valid-test checklist

Use these questions to confirm the test plan with your clinician:

• It's between 0700 and 1000 (or within 3 hours of waking, for shift workers)
• I'm fasting
• My clinician confirmed the required 30-day recovery interval after training involving extreme physical or mental stress or sleep deprivation
• I'm not acutely ill, and my clinician confirmed the required interval after recovery from acute illness
• I've told the provider about any opioids, steroids, or outside hormones I'm taking
• This is one of two tests on separate days

When you'll be sent to a specialist

The cause matters. If LH and FSH are high along with low testosterone, the problem is in the testicles (primary hypogonadism). That means a referral to urology or endocrinology. If they're low or normal, the guideline calls for more labs (prolactin, thyroid, iron studies, blood count) and an exam. It calls for pituitary imaging when testosterone is below 150 ng/dL, prolactin stays high, or there are visual-field problems or new or worsening headaches. DHA guideline, p. 7

Hypogonadism means your body doesn't make enough testosterone. More here: What is hypogonadism?

---

What TRT does the military actually prescribe?

The September 2026 DHA guideline lists several FDA-approved testosterone products. That means testosterone cypionate or enanthate injections (including an enanthate autoinjector), oral testosterone undecanoate, and 1.62% testosterone gel. The guideline lists no compounded testosterone products.

This is the guideline's implementation list, not the entire TRICARE formulary or a promise that a product is stocked, covered, or cleared for your duty. DHA guideline, Appendix C; TRICARE formulary and drug lists

FDA-approved means the FDA reviewed that specific product for safety and effectiveness. Compounded means a pharmacy mixed a custom preparation. The FDA does not approve compounded drugs. FDA compounding Q&A

FDA-approved testosterone products listed in the guideline

We compared the guideline's implementation list with testosterone and non-testosterone products a service member may encounter in civilian care. The differences matter for anyone who deploys or flies; listing a product here does not clear it for an assignment.

Sources: DHA guideline, Appendices A, C, and E; XYOSTED prescribing information; JATENZO prescribing information.

Compounded testosterone is a separate category

Sources: FDA compounding Q&A; OPSS testosterone guidance.

Non-testosterone alternatives and add-on medicines

These medicines are not TRT. Their role depends on the diagnosis and the specialist's assessment.

Sources: DHA guideline, Appendices A and C; PREGNYL label; CLOMID label; OPSS clomiphene and enclomiphene guidance; anastrozole label; FDA compounding Q&A.

Our takeaway: a civilian prescription does not establish military compatibility. Have the exact product and treatment plan reviewed by your military clinician before relying on it for duty or deployment. That's the single most useful filter if you're comparing options.

How the guideline uses the 300–600 range

The guideline describes a trough target of 300 to 600 ng/dL, including in its injection table. A trough is a level measured just before the next dose. But the guideline's own formulation table gives different sampling instructions for gel and directs clinicians to product labeling for oral testosterone.

Blood-test timing and interpretation depend on the exact formulation and product label; your prescriber sets that plan. For example, JATENZO's label uses a sample taken six hours after the morning dose, while XYOSTED has its own labeled trough range. Don't compare results from different sampling times as though they mean the same thing. DHA guideline, pp. 11 and 18; JATENZO label, section 2.2; XYOSTED label, section 2.2

We're describing the guideline, not recommending a dose or a target for you. Only your prescriber can do that.

---

Can you deploy on TRT?

Often, yes, but plan early because the rules stack. The DHA guideline says a member who is stable on testosterone should be deployable without a waiver, "depending on the formulation." An Army-hosted CENTCOM deployment standard lists testosterone as requiring a waiver, so your deployment medical team must confirm the current requirements for your orders.

The DHA guideline also requires a supply for the deployment plus 90 days, or a documented resupply pathway. Your deployment medical team coordinates review and routes any required waiver to the authorized decision-maker. DHA guideline, pp. 14–15; Army-hosted MOD 18 Tab A, sections 1.E and 7

Here's the catch we flagged at the top.

Two rulebooks, one prescription

Sources: DHA guideline; Army-hosted MOD 18 Tab A; TRICARE DPP.

These documents don't explicitly cancel each other. We found nothing showing that the DHA guideline overrides theater waiver rules. Don't assume "no waiver needed" because you read it in a headline. Ask your deployment medical team: "Which current theater rule applies to my prescription and these orders, and do I need a waiver?" Then get the answer documented.

One more point from the CENTCOM standard, worth reading twice: it recommends requesting a waiver rather than changing the way a stable medication is taken. Don't switch from injections to gel on your own to dodge a requirement.

Supply: the math that trips people up

The DHA guideline requires enough supply for the deployment plus 90 days, or a documented resupply plan. Two federal and program limits make that harder than it sounds:

• Federal law: a Schedule III prescription can be refilled no more than five times within six months of being written. After that, you need a new prescription (21 CFR 1306.22).
• TRICARE's Deployment Prescription Program: a 90-day supply at a time, no refills, for Schedule III drugs. A mailed prescription must be a paper original with the prescriber's handwritten signature and personal DEA number. Your provider can also fax it. TRICARE DPP

What that means in practice: on a 9-month deployment, "deployment plus 90 days" is about a year of coverage. The DPP's 90-day limit means you need to plan repeat prescribing and resupply; it does not mean you can collect a year's testosterone at once. Sort it out with your prescriber and pharmacy during pre-deployment processing.

Storage and custody

The guideline describes controlled room temperature storage for injectable testosterone (20–25 °C, with short trips allowed between 15 and 30 °C). They should be protected from light and never frozen. They also require Schedule III controlled-substance accountability at every echelon. The label for one common product, Depo-Testosterone, also lists controlled room temperature. So "all testosterone needs refrigeration" is wrong, though storage always depends on the exact product. Ask the pharmacist about yours. hCG is different: the PREGNYL label requires refrigeration after mixing. DHA guideline, Appendix C; DEPO-TESTOSTERONE label; PREGNYL label

What if you run out downrange?

Contact your deployed medical team promptly if supply is interrupted. The guideline treats an interrupted supply as a planned stop, calls for evaluation on return, and says the interruption itself is "not a medical emergency." That does not mean you should wait until you get home to ask for help.

Stopping suddenly can leave you feeling rough, and recovery of your own production is not assured. Your team should manage any interruption and its symptoms. That's one more reason to plan supply before you leave. DHA guideline, pp. 12 and 15

Deploying in the next few months? The worksheet below has a deployment section with the exact supply, storage, and waiver questions to ask during pre-deployment processing.

→ Get the deployment questions

---

Can pilots, divers, submariners, and nuclear personnel be on TRT?

Sometimes, but it's a separate decision from your treatment. The DHA guideline says both the diagnosis and the therapy can affect qualification for aeromedical, dive, submarine, and nuclear duty. Those decisions belong to your Service's authority under its own rules.

The 2026 guideline does not change them. DHA guideline, p. 15

If you hold one of these qualifications, the order of operations matters:

1. Talk to your flight surgeon or special-duty medical officer before starting anything. Not after.
2. Expect a review of the diagnosis itself, not just the medication. A diagnosis that doesn't meet guideline criteria is a problem for these reviews.
3. Report any outside treatment. Ask your aeromedical or special-duty medical office what clearance is required before returning to those duties.
4. Know your Service's rulebook exists. Ask that office for the current qualification guidance for your diagnosis and exact medication.

We're not going to give you a generic "wait three months" rule. Some pages do, but we couldn't trace those numbers to a current primary source for every Service and role. Your special-duty medical office has the real answer for your qualification.

Flying as a civilian pilot too? FAA medical certification has its own process. Ask your aviation medical examiner which current requirements apply. FAA low-testosterone disposition table

---

Can you use a civilian or online TRT clinic while on active duty?

A civilian prescription can be part of your care, but active-duty members still need military medical coordination. TRICARE generally requires referrals for active-duty care outside your assigned military clinic. Report outside care under your Service's rules.

Have your military clinician review the exact product before you pay for outside treatment. OPSS directs service members to FDA-approved testosterone. TRICARE referral rules; OPSS testosterone guidance

We'll be straight with you

A civilian prescription does not complete your military paperwork. Confirm who will send records, support a supply plan, and coordinate needed military review. If those are your priority, and on active duty they usually are, your military PCM is the better route. Covered prescriptions are also free for active-duty members through military pharmacies, TRICARE home delivery, and network retail pharmacies. DHA guideline, pp. 14–15; TRICARE pharmacy handbook, p. 19

Telehealth may make appointments easier for drilling Guard and Reserve members who already get their healthcare as civilians, and service members bridging care after they separate. Appointment availability still depends on the clinic. If that's you, skip to the Guard and Reserve section below.

If you're active duty and still want outside care

Do it in this order:

1. Ask your PCM first. TRICARE's referral rules say active-duty members generally need a referral for care outside their assigned military clinic, and TRICARE Prime active-duty members need pre-authorization for all specialty care. Paying cash doesn't erase the need to keep your military medical team informed.
2. Report it. Follow your Service's rules for outside treatment and prescriptions. An Air National Guard medical advisory quotes DAFMAN 48-123's requirement to report civilian medical and dental care, plus a separate Air Reserve Component rule to report previously unreported illness, injury, disease, procedures, or hospitalization within 72 hours to the commander or supervisor and supporting medical facility. An October 2012 MCIWEST-MCB Camp Pendleton order sets five working days for that command's outside care and prescriptions. Check the current rule for your Service and unit; these are not universal deadlines. Air National Guard advisory, p. 8; local Marine Corps order, section 3
3. Ask what you're getting. Is it FDA-approved or compounded? Which pharmacy dispenses it?
4. Get your records. Ask for both diagnostic lab results, your diagnosis, the exact product, and your monitoring plan, so your military clinician can review them. DHA guideline, Appendix B

Military compatibility checklist for any outside clinic

Ask these questions before you pay. A "no" or a vague answer is your signal to ask for clarification or use another care route.

• Can I get an FDA-approved testosterone product, not a compounded one?
• Will you send my full records and labs to my military clinician?
• For a new diagnosis, do you confirm low testosterone with two appropriately timed morning tests before starting treatment?
• Can you support a deployment-length supply plan within Schedule III refill limits?
• Do you ask about fertility plans before prescribing, and offer appropriate non-testosterone care or a specialist referral?
• What's the complete first-year cost, including both diagnostic tests, follow-up labs and visits, membership, medication, and shipping?
• What are the minimum commitment, cancellation, refund, and medical-record access terms?

Not sure whether military or civilian care is your better starting point? Ask your PCM about referrals, reporting, and records before you book.

→ Prepare your outside-care questions

---

What if you want kids? TRT and fertility in the military

Under the September 2026 DHA guideline, testosterone is not started when fertility is desired or undecided. Testosterone can reduce or stop sperm production. The guideline instead points to specialist-directed hCG or clomiphene, which are not TRT and do not guarantee fertility.

PREGNYL, an hCG product, is FDA-approved for selected cases of male hypogonadotropic hypogonadism; clomiphene is used off-label for male hypogonadism. The guideline also calls for a semen analysis and a conversation about sperm banking when appropriate. Your fertility plans must be recorded before any prescription. DHA guideline, p. 9; PREGNYL label; CLOMID label

This is the question to answer before your appointment, not after.

Why testosterone affects sperm

Outside testosterone suppresses LH and FSH signaling, which can reduce or stop sperm production. Making sperm is called spermatogenesis. The guideline says outside testosterone "reliably impairs" it.

Recovery after stopping is possible, but not guaranteed. The pooled analysis the guideline cites studied 1,549 healthy men aged 18–51 with normal baseline hormone function in 30 hormonal male-contraception studies. Its outcome was recovery of sperm concentration to at least 20 million/mL.

These were not men with established hypogonadism receiving long-term TRT. Sperm concentration is not a pregnancy rate, and these estimates do not predict an individual's recovery. Liu and colleagues, original study

A separate study of 66 men treated for testosterone-associated infertility found that older age and longer testosterone use were linked to slower sperm recovery after stopping testosterone and starting specialist treatment. That study involved hCG and medicines that affect hormone signaling; it was not a forecast of untreated recovery. Persistent azoospermia (no sperm in the semen) cannot be ruled out. DHA guideline, p. 9 No one can promise you'll recover on a set timeline. Kohn and colleagues, original study

hCG and clomiphene aren't TRT

They work differently. They push your own body to make more testosterone rather than replacing it. They're not interchangeable with testosterone, and they're not "natural TRT."

The Endocrine Society raised a specific concern in its September 24, 2026 statement. In men whose low testosterone is tied to obesity, it warned that hCG can suppress FSH, a hormone sperm production needs. That could reduce sperm production. It also noted that two or more years of TRT plus hCG can delay recovery. That's a good reason to involve a reproductive urologist if kids are on your near-term list. The guideline says that referral should be offered. Endocrine Society's September 2026 statement; DHA guideline, p. 9

More detail: TRT and fertility · hCG with TRT · hCG vs. clomiphene

→ Read our fertility guide before your appointment

---

What are the risks, and what does the military monitor?

The DHA guideline identifies raised hematocrit—more of your blood made up of red blood cells—as the most common side effect. It calls for checks before treatment, at 4 to 6 weeks, and every 6 months after that. The exact product label or your health history may require more frequent checks.

For example, JATENZO and XYOSTED labeling calls for hematocrit checks about every three months. The DHA guideline also calls for reassessment 4–6 weeks after a dose or formulation change, yearly PSA (prostate-specific antigen) testing in men over 40 or at high risk for prostate cancer, and blood-pressure checks at each monitoring visit. Certain conditions rule treatment out until they're evaluated. DHA guideline, pp. 11–12; JATENZO label, section 5.1; XYOSTED label, section 5.1

Hematocrit is the share of your blood made up of red blood cells. Testosterone can raise it.

The guideline's hematocrit action levels

The guideline is candid that the 54% threshold is a conservative cutoff carried over from other blood conditions, not something proven by outcome studies in men on TRT. DHA guideline, p. 12

These are clinician decision points. Contact your treating team about an abnormal result; do not arrange blood removal or change treatment on your own using this table.

Other checks and warning signs

• PSA: the DHA guideline calls for referral to urology above 3.0 ng/mL, or a rise of more than 1.0 ng/mL within 12 months. These are its referral thresholds, not a self-diagnosis of cancer.
• Heart: The TRAVERSE trial found a similar rate of major cardiovascular events with 1.62% testosterone gel and placebo in men aged 45–80 with hypogonadism and existing or high cardiovascular risk. It did find more atrial fibrillation (an irregular heartbeat), acute kidney injury, and pulmonary embolism (a blood clot in the lungs) in the testosterone group. The guideline warns that those older-patient results don't map cleanly onto younger troops. Original TRAVERSE study
• Other effects: higher blood pressure, acne, injection-site reactions, breast enlargement, swelling. Gels can transfer to partners or kids through skin contact.

When treatment shouldn't start

The guideline lists these as absolute reasons not to start:

• untreated or metastatic prostate cancer
• male breast cancer
• an unevaluated prostate nodule or PSA rise
• allergy to the product
• a current desire for fertility (for testosterone specifically)

Relative reasons, where caution or more evaluation is needed, include:

• baseline hematocrit above 50% pending evaluation
• untreated sleep apnea
• a recent heart attack, acute coronary syndrome, or stroke (within 6 months)
• uncontrolled heart failure or high blood pressure
• a clotting disorder such as thrombophilia, or prior unprovoked blood clots
• severe urinary symptoms

Source: DHA guideline, p. 12.

Get emergency care for chest pain, trouble breathing, sudden one-sided leg swelling, or stroke signs like face drooping or sudden weakness.

More: TRT side effects · Who should not take TRT

---

How much does TRT cost in the military?

For active-duty members, covered prescriptions cost $0 at military pharmacies, TRICARE Pharmacy Home Delivery, and TRICARE retail network pharmacies. TRICARE covers hormone replacement therapy through its pharmacy benefit when the drug is FDA-approved and used for a labeled purpose. Guard and Reserve members in civilian status pay through civilian insurance, TRICARE Reserve Select, or cash.

TRICARE specifically states that active-duty members receive full reimbursement for covered drugs filled through overseas retail pharmacies, subject to the applicable pharmacy and claims rules. That overseas statement should not be read as a blanket promise for every non-network purchase. TRICARE retail pharmacy rules; pharmacy handbook, pp. 13 and 19

The $0 statement above is about covered medication. Confirm coverage and required authorization for the evaluation, repeat testing, and follow-up separately. An off-label option appearing in a clinical guideline does not itself establish TRICARE coverage. TRICARE HRT benefit; referral and authorization rules

Two things TRICARE coverage does not mean:

• It doesn't mean a specific compounded product is covered.
• It doesn't mean you're cleared to deploy, fly, or join. Coverage and clearance are different decisions made by different offices.

For prior authorization, formulary checks, and beneficiary-group costs, see our full guide: Does TRICARE cover TRT?

→ Check the TRICARE requirements for your prescription

---

Can Guard and Reserve members be on TRT?

Yes, prescribed TRT can be compatible with Guard or Reserve service. The July 2026 screening initiative includes Reserve Component members 30 and older. Drilling members may receive care through a civilian doctor or online program.

The rules that matter don't change: you need a lawful prescription, you must report civilian care under your Service's rules, and deployment requires a supply and clearance plan.

If you're a drilling Guardsman or Reservist, you live in two worlds. Your day-to-day care may be civilian. Your readiness is military. TRT has to work in both.

What drilling members need to do

• Report civilian care. The Air National Guard advisory quotes a 72-hour Air Reserve Component reporting rule for previously unreported illness, injury, disease, procedures, or hospitalization, alongside the duty to report civilian medical and dental treatment. Send records through your unit's required process. Other Services have their own reporting rules, so check yours. Air National Guard advisory, p. 8
• Keep your records portable. Have both diagnostic labs, your diagnosis, your exact product, and your monitoring results ready for your unit medical section.
• Plan for mobilization now. If you're activated for deployment, confirm the requirements for your orders: stability, supply for the deployment plus 90 days or a documented resupply pathway, storage, and any theater waiver. DHA guideline, pp. 14–15

If you're going to use an online program

This is where online care can genuinely fit. A drilling member who already uses civilian care can consider telehealth, but passing this checklist does not replace military coordination or qualification review.

The questions to settle, given your military status:

• an FDA-approved testosterone product
• documented diagnostic testing, including two morning tests before starting treatment for a new diagnosis
• records you can hand to your unit
• a real answer on fertility
• a complete first-year cost, not a teaser price

As checked October 30, 2026, federal rules let DEA-registered clinicians prescribe controlled substances like testosterone through qualifying audio-video telemedicine visits without a prior in-person examination, under a temporary extension that runs through December 31, 2026. The prescription must be for a legitimate medical purpose and comply with federal and state law. DEA announcement; HHS announcement If that federal extension lapses or changes, some online programs may need to change how they start new patients. Ask about it before you sign up.

For general online-program information after those military questions are settled, you can use Find My TRT Path. It's educational, and it doesn't decide medical eligibility or military clearance.

Considering civilian online care? → Use Find My TRT Path for general online-program information

---

Can you join the military if you're already on TRT?

Joining is judged by different medical standards from staying in. The published entry standards list a history of hypogonadism that is "treated with hormonal supplementation," congenital, or unexplained as a disqualifying condition. Any waiver depends on the accession process, and approval can't be assumed.

A separate entry standard covers injectable or transdermal hormones. Health.mil entry standards, sections 6.24 and 6.30; accession and retention overview

What the entry standards say

The military's published list of disqualifying conditions for entry includes these two items:

• Endocrine section: "History of hypogonadism that is congenital, treated with hormonal supplementation, or of unexplained etiology."
• Miscellaneous section: current use of medication delivered by injection or through the skin, including hormones, is disqualifying unless the treating provider confirms in writing that it can be safely postponed, discontinued, or changed to another delivery method without adverse risk if the current method is unavailable or not authorized during training or deployment.

Meeting that delivery-method exception does not erase a separate disqualification for hypogonadism. These are accession rules, not instructions to change your medication. Health.mil entry standards, sections 6.24 and 6.30

Waivers are considered through the accession medical process. A recruiter can help you find that process, but a recruiter isn't the medical waiver authority.

What not to do

• Don't hide it. Full disclosure is required.
• Don't stop or switch treatment on your own to try to meet an entry rule. Talk to your prescriber and the accession medical team first.
• Don't rely on someone else's story. Another person's waiver, a forum post, or a clinic's willingness to prescribe tells you nothing about your own case.

---

What happens to your TRT when you leave the military?

Your care and pharmacy coverage can change when active-duty care ends, so plan the handoff before you separate. Get your full lab history and diagnosis records, then line up continuing care through TRICARE if eligible, VA, or a civilian prescriber. Don't let a gap in supply force an unplanned interruption.

Separation, retirement, and Reserve deactivation have different benefit rules. TRICARE says prescriptions remain valid until their expiration date when you retire; continued pharmacy coverage still requires the right plan enrollment. Some separating members qualify for 180 days of Transitional Assistance Management Program coverage, and other transition options may apply. Confirm your coverage and next prescriber before your last active-duty appointment. TRICARE separation; retirement; TAMP; deactivation

Your separation checklist

• Both diagnostic testosterone tests, with dates and times
• LH, FSH, and any other workup results
• Your diagnosis and its documented cause
• Your exact product, dose history, and latest testosterone result with its timing relative to medication
• Hematocrit and PSA trends
• Any fertility discussion or semen analysis
• A clinician-approved continuity plan that covers the gap until your next prescriber

Don't assume the same prescriber, coverage, or refill arrangements carry over automatically. Ask who will handle your next visit, lab review, and prescription.

Next steps: Does the VA cover TRT? If you're considering civilian online care after separation, Find My TRT Path offers general online-program information; it does not arrange a transfer of care or establish benefit eligibility.

→ Explore general online TRT program information

---

Why is the military's testosterone policy controversial?

The Pentagon says screening supports readiness and long-term health. The Endocrine Society says population-level blood-test screening of men without symptoms is not supported and raises concerns about false positives and fertility. The DHA guideline's actual pathway starts with a symptom and risk-factor screen and requires confirmed deficiency before treatment.

On one side, the Department frames the program as investing in warfighter health and readiness. On the other, the Endocrine Society said in September 2026 that population-level screening of men without symptoms isn't supported by the evidence, and that screening men over 30 is likely to produce many false positives. DHA announcement; Endocrine Society statement

What matters for you is simpler. The DHA pathway described here requires symptoms, two valid tests, a fertility conversation, and ongoing monitoring. Use that standard, whatever you think of the headlines.

---

Military TRT Appointment Worksheet

Print this and bring it to your PCM, PHA, or deployment medical team. It turns a vague conversation into specific answers: who decides each part of your care, and what's still unresolved. It's our editorial discussion aid, not an official military form, and it isn't a clearance or eligibility test.

Keep it private. Do not post it publicly or submit it to this site. Share medical information only through your care team's approved channels. Leave off your name, ID numbers, unit, and deployment dates or locations. Skip anything that doesn't apply.

1. What decision do I need?

• Medical evaluation or ongoing treatment
• Deployment clearance
• Special-duty qualification
• Continuing service
• Joining or commissioning
• Civilian referral, coverage, or pharmacy

Which comes first? ______________________________

2. Who decides?

3. Is my diagnosis solid?

• Were both tests fasting, on separate days, between 0700 and 1000—or within three hours of habitual waking after normal sleep for night or rotating shifts?
• Did my clinician confirm the required recovery interval after qualifying extreme training, sleep loss during training, or acute illness?
• Were LH and FSH checked? What's the likely cause?
• Should free testosterone be checked?
• Is something else (sleep, weight, medications, mood, thyroid) driving my symptoms?

4. Fertility, before anything is prescribed

• Do I want children now, soon, or someday?
• If yes or unsure: what are my non-testosterone options?
• Should I get a semen analysis or discuss sperm banking?
• Should I see a reproductive urologist?

5. The exact medication

• What product and format? Is it FDA-approved or compounded?
• Is it on the military formulary?
• Does this format affect deployment or special duty?

Product: ______________________________

6. Deployment and supply

• Is a waiver required for my prescription under the theater rules for my orders?
• If treatment is new or has changed, when is my 4–6 week review, and will stability be confirmed before departure?
• How will I cover the deployment plus 90 days, or arrange a documented resupply pathway, given the Schedule III prescription limits?
• Who writes my next prescription while I'm deployed?
• How will it be stored and accounted for?
• Who do I contact if supply is delayed?

7. Monitoring

• When should my testosterone sample be drawn for this exact product, and when are my hematocrit checks?
• Do I need yearly PSA tests?
• Who tracks the results if I PCS or deploy?

8. Before I leave the room

Still pending: ______________________________

Who owns it: ______________________________

What I need to bring or arrange: ______________________________

How I'll get the answer: ______________________________

Don't change or stop prescribed treatment to solve a paperwork problem without talking to your treating clinician first.

---

How we researched this guide

We built this page from primary military, medical, pharmacy, and regulatory documents checked on October 30, 2026. It shows what each source decides and where your own military team must confirm the rule for your case. It's editorial research, not a clinical or military determination, and it doesn't recommend any clinic.

What we actually verified

• Date checked: October 30, 2026
• Documents reviewed:
  • DHA memo and Clinical Practice Guideline for Testosterone Deficiency in the Male Service Member (signed September 17, 2026), including its appendices
  • DHA screening announcement, Men's Hormone Health page, and separately linked patient handout
  • Health.mil's published accession disqualifying conditions and accession/retention overview
  • Publicly posted Army-hosted copy of CENTCOM MOD 18, Tab A
  • TRICARE Deployment Prescription Program page (updated September 28, 2026), pharmacy handbook, retail pharmacy rules, referral rules, HRT benefit, and transition-benefit pages
  • Endocrine Society guideline and September 24, 2026 statement
  • Current product prescribing information for the formulation and monitoring distinctions discussed here
  • Original published study abstracts for the fertility-recovery figures and TRAVERSE results
  • 21 CFR 1306.22, UCMJ Article 112a, DEA scheduling and prescribing guidance, and official DEA/HHS telemedicine announcements
  • Air National Guard's April 2024 medical advisory quoting reporting rules, and the October 2012 MCIWEST-MCB Camp Pendleton outside-care order, with their date and local scope identified
• Historical reporting checked: the Pentagon's September 2 statement in an archived reprint, and Military Times reporting published by Army Times on the September 2–3 withdrawal. These establish the timeline; clinical and duty claims rely on the primary documents linked above.
• Facts confirmed:
  • The diagnostic criteria, testing rules, listed treatment options, monitoring thresholds, deployment and supply requirements, and duty-status statements in the DHA guideline
  • The differences between the guideline's general monitoring language and specific product labeling
  • The testosterone and injectable-medication waiver language in the Army-hosted MOD 18 Tab A copy
  • The Schedule III 90-day/no-refill DPP rule, distinct from federal prescription-refill limits
  • The hypogonadism and injectable/transdermal-medication entry standards
  • The population and measured outcome behind the fertility-recovery table
• Provider-stated facts used: none. This page doesn't recommend a specific clinic.
• Not established:
  • Your individual eligibility, clearance, waiver outcome, or retention outcome
  • Whether newer theater guidance has changed the MOD 18 waiver language for your orders
  • Specific aeromedical waiting periods for every Service and role
• Review status: editorial research; not clinically reviewed.
• Method: How We Review TRT Providers, applied here to source transparency and limits rather than provider scoring.

If a source seems to disagree with another, don't pick one yourself. Ask the responsible military office which current document applies, and write down the document name and date.

---

Frequently asked questions

Military TRT decisions depend on the diagnosis, your duty status, the exact prescription, and assignment rules. Use these answers to prepare questions for the responsible military medical team.

Can you be on TRT in the military?

Yes, prescribed TRT can be compatible with service when the diagnosis, documentation, and applicable military medical requirements are addressed. The September 2026 DHA guideline says stable treatment isn't, by itself, a reason for a duty limitation. Entry, special-duty, retention, and theater deployment decisions still follow their own rules. DHA guideline; medical standards

Is TRT considered a steroid in the military?

Testosterone is an anabolic-androgenic steroid and a Schedule III controlled substance. With lawful prescribing for a diagnosed deficiency, it's medical treatment. Wrongful use, possession, or distribution can be charged under UCMJ Article 112a. DEA scheduling; UCMJ Article 112a

Does TRT make you non-deployable?

Not automatically. The DHA guideline says stable members should be deployable without a waiver, depending on formulation. The publicly posted Army-hosted CENTCOM copy lists testosterone and injectables as needing a waiver. Ask your deployment medical team which current rule applies to your orders and who decides any waiver. DHA guideline; Army-hosted MOD 18 Tab A

Can I start TRT right before a deployment?

The DHA guideline allows initiation within 90 days of deployment, but requires the 4–6 week review to establish stability before departure, with no further titration needed. Its continuity requirement is supply for the deployment plus 90 days, or a documented resupply pathway. Your military team must also confirm the applicable theater and duty rules. DHA guideline, pp. 2 and 14–15

Does the military test everyone's testosterone now?

Men 30 and older get a symptom and risk-factor screen at their Periodic Health Assessment. Under that pathway, blood tests follow a positive screen or a listed risk factor, subject to valid-testing conditions. Men under 30 can request screening or be screened when their provider identifies clinical indicators. DHA guideline, pp. 4–5

Can I get TRT if I'm under 30?

Being under 30 does not rule out TRT. Screening is available on request, or when your provider sees clinical signs. The same diagnostic and military requirements apply. DHA guideline, pp. 4–5

Do I have to report TRT from a civilian doctor?

Report outside treatment and prescriptions through your Service's required process. The Air Reserve Component's quoted 72-hour rule covers specified previously unreported medical conditions and events; it is not a universal deadline for every Service. DHA also asks members to tell their provider about any hormones obtained outside their military care. Air National Guard advisory; DHA patient guidance

Can I switch from injections to gel to make deploying easier?

Don't make that change on your own. The CENTCOM deployment standard actually recommends requesting a waiver rather than changing the route of a stable, effective medication. Any switch should be a clinical decision with your prescriber and deployment medical team.

Will TRT affect my flight status?

It can. Aeromedical qualification is decided separately by your Service. See your flight surgeon or aeromedical provider before starting treatment, and ask what clearance is needed before reporting for flight duty. DHA guideline, p. 15

Will the military prescribe testosterone if I want kids?

Under the September 2026 DHA guideline, testosterone is not started when fertility is desired or undecided. It lists specialist-directed hCG or clomiphene, plus semen analysis and a sperm-banking discussion when appropriate. Those medicines are not TRT, and none guarantees fertility. DHA guideline, p. 9

Does TRICARE cover TRT for active duty?

Covered prescriptions cost active-duty members $0 at military pharmacies, home delivery, and network retail pharmacies. TRICARE's HRT benefit applies to FDA-approved drugs used for labeled purposes. Coverage doesn't equal deployment or duty clearance.

Is compounded testosterone allowed?

Do not assume a civilian compounded prescription is approved for military use. Compounded testosterone is not FDA-approved, is not listed in the September 2026 DHA guideline, and OPSS directs service members to FDA-approved testosterone. Ask your PCM or special-duty medical officer to review the exact product. FDA compounding Q&A; OPSS guidance

Can Guard and Reserve members be on TRT?

Yes, prescribed TRT can be compatible with Guard or Reserve service. Report civilian care to your unit medical section on time. If activated for deployment, confirm the supply, stability, and clearance requirements for your orders. DHA guideline, pp. 14–15

Can you join the military on TRT?

Entry standards list hormone-treated hypogonadism as disqualifying, and waivers depend on the accession process. Disclose it fully. Don't stop or change treatment on your own to try to qualify.

What happens if I stop TRT?

Stopping after long-term use can bring symptoms and needs follow-up. The DHA guideline counsels that recovery of hormone and sperm production after sustained exposure may take 6–24 months, but recovery is not assured and underlying hypogonadism may persist. Any elective taper is planned by the treating clinician; do not stop or change treatment yourself. DHA guideline, p. 12

---

Still comparing general online TRT programs? Use our free Find My TRT Path tool.

If you're serving or applying, confirm the military medical path first. Find My TRT Path is general education. It doesn't decide military clearance, and it isn't a way around your care team.

---

Sources

• Defense Health Agency. Memorandum and Clinical Practice Guideline: Testosterone Deficiency in the Male Service Member. Signed September 17, 2026. Clinical testing, treatment, fertility, monitoring, deployment, and documentation sections.
• Defense Health Agency. Department releases guidance on implementing testosterone deficiency screenings. September 18, 2026.
• Defense Health Agency. Men's Hormone Health and Patient Information Sheet: Testosterone Therapy. Checked October 30, 2026.
• Defense Visual Information Distribution Service. Secretary of War announces testosterone screening program. Official announcement record dated July 15, 2026.
• Health.mil. Medical Accessions: Disqualifying Conditions, sections 6.24 and 6.30; Accessions and Medical Standards.
• USCENTCOM. MOD 18 Tab A: Amplification of the Minimal Standards of Fitness for Deployment, publicly posted Army-hosted copy; sections 1.E, 7.A.8, 7.I.7.f, and 7.I.15.
• TRICARE. Deployment Prescription Program. Updated September 28, 2026.
• TRICARE. Pharmacy Program Handbook, September 2026, especially pp. 13 and 19; Network and Non-Network Pharmacies.
• TRICARE. Referrals and Pre-Authorizations; Hormone Replacement Therapy; Health.mil, TRICARE Formulary and Drug Lists.
• TRICARE. Separating From Active Duty; Retiring; Transitional Assistance Management Program; Deactivating.
• U.S. Code. 10 USC 912a: UCMJ Article 112a, wrongful use, possession, and distribution of controlled substances.
• Electronic Code of Federal Regulations. 21 CFR 1306.22: Refilling of prescriptions for Schedules III and IV.
• Drug Enforcement Administration. Drug Scheduling and Prescriptions Q&A.
• DEA. DEA Extends Telemedicine Flexibilities to Ensure Continued Access to Care. December 31, 2025. HHS. Telemedicine extension through 2026. January 2, 2026.
• Endocrine Society. Testosterone Therapy in Men with Hypogonadism, 2018; statement on the DHA guideline, September 24, 2026.
• FDA. Compounding and the FDA: Questions and Answers.
• FDA/DailyMed prescribing information. XYOSTED; JATENZO; DEPO-TESTOSTERONE; PREGNYL; CLOMID; anastrozole. Product-specific approval, route, food, monitoring, and storage information checked October 30, 2026.
• Liu PY and colleagues. Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis. Lancet. 2006;367:1412–1420.
• Kohn TP and colleagues. Age and duration of testosterone therapy predict time to return of sperm count after human chorionic gonadotropin therapy. Fertility and Sterility. 2017;107:351–357.e1.
• Lincoff AM and colleagues. Cardiovascular Safety of Testosterone-Replacement Therapy. New England Journal of Medicine. 2023;389:107–117.
• Air National Guard Chief Medical Review Officer advisory. Plane Talk, 167th Airlift Wing, April 2024, p. 8. Quotes DAFMAN 48-123 reporting provisions; archived copy of the government publication.
• Marine Corps Installations West-Marine Corps Base Camp Pendleton. Order 6000.1: Reporting of Prescribed Medications and Medical Treatment Outside the Military Health System. October 1, 2012. Local reporting example; check current unit requirements.
• Operation Supplement Safety. Questions and Answers About Testosterone; Clomiphene and Enclomiphene: Drugs, Not Dietary Supplements, content current January 12, 2026.
• U.S. Army Fort Hood. Drug Testing Lab. Official description confirming steroid testing; local procedures are not generalized to every Service.
• Federal Aviation Administration. Low Testosterone / Hypogonadism Disposition Table. Updated April 29, 2026.
• Pentagon spokesman. September 2, 2026 statement on the earlier clinical guidance, archived reprint. Used for the historical timeline.
• Military Times / Army Times. Pentagon updates guidance on low testosterone testing for males. September 18, 2026. Used for the September 2–3 withdrawal timeline.